|
CA2581810C
(en)
|
2004-10-26 |
2013-12-17 |
Dolby Laboratories Licensing Corporation |
Calculating and adjusting the perceived loudness and/or the perceived spectral balance of an audio signal
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2009067493A2
(en)
*
|
2007-11-19 |
2009-05-28 |
Envivo Pharmaceuticals, Inc. |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
EA201270666A1
(ru)
|
2007-11-27 |
2012-12-28 |
Ардеа Биосайнсиз Инк. |
Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
|
|
JP2011507909A
(ja)
|
2007-12-20 |
2011-03-10 |
エンビボ ファーマシューティカルズ インコーポレイテッド |
四置換ベンゼン
|
|
US8242154B2
(en)
|
2008-09-04 |
2012-08-14 |
Ardea Biosciences, Inc. |
Compounds, compositions and methods of using same for modulating uric acid levels
|
|
EP2367839A4
(en)
*
|
2008-11-03 |
2012-07-04 |
Univ Tufts |
METHOD AND COMPOSITIONS FOR INHIBITING CLOSTRIDIUM DIFFICILE SPORTS NUTRITION AND GROWTH
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
EP2519100B1
(en)
|
2009-12-29 |
2017-03-15 |
Mapi Pharma Limited |
Intermediate compounds and processes for the preparation of tapentadol and related compounds
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
CA2797118C
(en)
|
2010-04-22 |
2021-03-30 |
Vertex Pharmaceuticals Incorporated |
Process of producing cycloalkylcarboxamido-indole compounds
|
|
AR081930A1
(es)
|
2010-06-16 |
2012-10-31 |
Ardea Biosciences Inc |
Compuestos de tioacetato
|
|
EP2582664A4
(en)
|
2010-06-16 |
2014-07-09 |
Ardea Biosciences Inc |
PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
|
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120053A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
UA114304C2
(uk)
|
2011-11-03 |
2017-05-25 |
Ардеа Біосайєнсіс, Інк. |
Спосіб зниження сироваткових рівнів сечової кислоти у людини
|
|
US9084826B2
(en)
|
2012-05-01 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid conjugates of statin and FXR agonists; compositions and method of uses
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
CN111529534A
(zh)
|
2012-09-27 |
2020-08-14 |
儿童医学中心公司 |
用于治疗肥胖症的化合物和其使用方法
|
|
JP6422452B2
(ja)
*
|
2013-03-14 |
2018-11-14 |
ユニバーシティ オブ マカオＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍａｃａｕ |
ヤクチ（益智（ａｌｐｉｎｉａｅｏｘｙｐｈｙｌｌａｅｆｒｕｃｔｕｓ））およびその全合成から単離される新規な抗神経変性天然化合物
|
|
CA2944140C
(en)
|
2014-04-15 |
2022-10-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
|
|
SG11201703717SA
(en)
*
|
2014-11-06 |
2017-06-29 |
Enanta Pharm Inc |
Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
|
|
KR20170099909A
(ko)
|
2014-11-26 |
2017-09-01 |
이난타 파마슈티칼스, 인코포레이티드 |
Fxr/tgr5 작용제로서의 담즙산 유사체 및 이의 이용 방법
|
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
CN107249594A
(zh)
|
2015-02-11 |
2017-10-13 |
英安塔制药有限公司 |
作为fxr/tgr5激动剂的胆汁酸类似物及其使用方法
|
|
SG10201910670RA
(en)
|
2015-03-31 |
2020-01-30 |
Enanta Pharm Inc |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
WO2017147137A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Benzoic acid derivatives of bile acid as fxr/tgr5 agonists and methods of use thereof
|
|
US10364267B2
(en)
|
2016-02-23 |
2019-07-30 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
WO2017147174A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
|
|
DE102017005884A1
(de)
*
|
2016-07-07 |
2018-01-11 |
Merck Patent Gmbh |
Elektronisches Schaltelement
|
|
JP7057783B2
(ja)
|
2016-11-29 |
2022-04-20 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
スルホニル尿素胆汁酸誘導体の調製方法
|
|
US10472386B2
(en)
|
2017-02-14 |
2019-11-12 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR agonists and methods of use thereof
|
|
BR112019020780A2
(pt)
|
2017-04-07 |
2020-04-28 |
Enanta Pharm Inc |
processo para preparação de derivados de ácido biliar de carbamato de sulfonila
|
|
DE102018004733A1
(de)
|
2018-06-14 |
2019-12-19 |
Merck Patent Gmbh |
Verfahren zur Herstellung eines elektronischen Bauteils enthaltend eine selbstorganisierte Monolage
|
|
CN116925168A
(zh)
*
|
2019-08-23 |
2023-10-24 |
深圳云合医药科技合伙企业(有限合伙) |
胆汁酸衍生物及其组合物和应用
|
|
CN117751130A
(zh)
*
|
2021-07-26 |
2024-03-22 |
沙裴隆有限公司 |
一种抑制TNF-α生成和炎症小体活性的新型化合物及其制备方法
|